Human spermatagonial stem cells: A novel therapeutic hope for cardiac regeneration and repair?

Publikation: Beitrag in FachzeitschriftÜbersichtsartikel (Review)BeigetragenBegutachtung

Beitragende

  • Kaomei Guan - , Institut für Pharmakologie und Toxikologie, Universitätsmedizin Göttingen, Georg-August-Universität Göttingen (Autor:in)
  • I. Fen Cheng - , Georg-August-Universität Göttingen (Autor:in)
  • Maryam Baazm - , Georg-August-Universität Göttingen, Tehran University of Medical Sciences (Autor:in)

Abstract

Although the identification and characterization of human spermatogonial stem cells was reported nearly 50 years ago, great progress has been made only in the last few years. Spermatogonial stem cells attract a great deal of researchers’ attention because of their unique characteristics, including the ability to be converted spontaneously into pluripotent germline stem cells with embryonic stem cell-like properties. Pluripotent stem cells are able to differentiate into any desired cell type in the body; therefore, they are the most promising cell source for organ regeneration. The advantages of pluripotent germline stem cells over other stem cells are that they maintain a high degree of DNA integrity and can resolve some ethical and immunological problems related to human embryonic stem cells. In this article we address the origin, characteristics and pluripotency of spermatogonial stem cells. Their contribution to stem cell-based organ regeneration therapy with special emphasis on cardiac regeneration and repair in the future is also discussed.

Details

OriginalspracheEnglisch
Seiten (von - bis)39-51
Seitenumfang13
FachzeitschriftFuture Cardiology
Jahrgang8
Ausgabenummer1
PublikationsstatusVeröffentlicht - Jan. 2012
Peer-Review-StatusJa

Externe IDs

PubMed 22185445

Schlagworte

Ziele für nachhaltige Entwicklung

Schlagwörter

  • cardiac differentiation, germline stem cells, heart regeneration, human, mouse, pluripotency, spermatogonial stem cells, testis